Consensus Enlivex

Stocks

ENLV

IL0011319527

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-10 EDT			5-day change	1st Jan Change
6.860 ^USD	-7.30%		-13.32%	-34.96%

06-15	Enlivex Therapeutics Granted Patent in Australia for Allocetra to Treat Osteoarthritis	MT
06-01	Enlivex Ltd. Presents Durable 6-Month Efficacy Data For Allocetra In Knee Osteoarthritis Phase IIa Trial	CI

Evolution of the Average Target: Enlivex

Evolution of the Target Price: Enlivex

Changes in Analyst Recommendations: Enlivex

afcfc.xC9l2QoWOcuer_JhgWl03jHAJR80R8C-wUe8OwQ5EsI.vGNQvE1gfKH2mrUv4lEA6n7xUEADDe39inSJYzBpa6-Ddyyva0FziqbIuw~9f41b7837640e80f9cda71696177243a

Analysts' recommendations: Enlivex

24-06-11	HC Wainwright Adjusts Price Target on Enlivex Therapeutics to $6 From $7, Maintains Buy Rating	MT
24-04-12	HC Wainwright Adjusts Enlivex Therapeutics Price Target to $7 From $12, Maintains Buy Rating	MT
23-09-25	HC Wainwright Cuts Enlivex Therapeutics Price Target to $12 From $15, Maintains Buy Rating	MT
22-05-02	HC Wainwright Adjusts Enlivex Therapeutics' Price Target to $15 from $33, Keeps Buy Rating	MT

More recommendations

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

6.860USD

Average target price

300.00USD

Spread / Average Target

+4,273.18%

High Price Target

300.00USD

Spread / Highest target

+4,273.18%

Low Price Target

300.00USD

Spread / Lowest Target

+4,273.18%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

HC Wainwright

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

6.860USD

Average target price

300.00USD

Spread / Average Target

+4,273.18%

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Stock Market
Stocks
ENLV Stock
Consensus Enlivex

Google lets you customize your preferred sources.

G Google

Choose MarketScreener

G Google

Choose MarketScreener